{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:26:33Z","timestamp":1768483593451,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T00:00:00Z","timestamp":1280448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10549-010-1082-x","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T12:32:20Z","timestamp":1280406740000},"page":"157-165","source":"Crossref","is-referenced-by-count":24,"title":["Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study"],"prefix":"10.1007","volume":"126","author":[{"given":"Theodore M.","family":"Brasky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten B.","family":"Moysich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather M.","family":"Ochs-Balcom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalin","family":"Marian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine B.","family":"Ambrosone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng Hua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Edge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo L.","family":"Freudenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,30]]},"reference":[{"key":"1082_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867 (see comment)","journal-title":"Nature"},{"key":"1082_CR2","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/jnci\/djn324","volume":"100","author":"B Takkouche","year":"2008","unstructured":"Takkouche B, Regueira-M\u00e9ndez C, Etminan M (2008) Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 100:1420\u20131423","journal-title":"J Natl Cancer Inst"},{"key":"1082_CR3","doi-asserted-by":"publisher","unstructured":"Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL (2010) Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control. doi: 10.1007\/s10552-010-9579-5","DOI":"10.1007\/s10552-010-9579-5"},{"key":"1082_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1432-1033.1994.tb18804.x","volume":"221","author":"T Kosaka","year":"1994","unstructured":"Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, Tanabe T (1994) Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem 221:889\u2013897","journal-title":"Eur J Biochem"},{"key":"1082_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/bcr1678","volume":"9","author":"LR Howe","year":"2007","unstructured":"Howe LR (2007) Inflammation and breast cancer. Cyclooxygenase\/prostaglandin signaling and breast cancer. Breast Cancer Res 9:210","journal-title":"Breast Cancer Res"},{"key":"1082_CR6","first-page":"1676","volume":"62","author":"E Half","year":"2002","unstructured":"Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA (2002) Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 62:1676\u20131681","journal-title":"Cancer Res"},{"key":"1082_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/jnci\/90.6.455","volume":"90","author":"D Hwang","year":"1998","unstructured":"Hwang D, Scollard D, Byrne J, Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90:455\u2013460","journal-title":"J Natl Cancer Inst"},{"key":"1082_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.anndiagpath.2006.03.002","volume":"10","author":"C Leo","year":"2006","unstructured":"Leo C, Faber S, Hentschel B, Hockel M, Horn L-C (2006) The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. Ann Diagn Pathol 10:327\u2013332","journal-title":"Ann Diagn Pathol"},{"key":"1082_CR9","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1158\/1078-0432.CCR-08-0716","volume":"15","author":"JE Abraham","year":"2009","unstructured":"Abraham JE, Harrington P, Driver KE, Tyrer J, Easton DF, Dunning AM, Pharoah PD (2009) Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival. Clin Cancer Res 15:2181\u20132191","journal-title":"Clin Cancer Res"},{"key":"1082_CR10","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/bcr1635","volume":"9","author":"DG Cox","year":"2007","unstructured":"Cox DG, Buring J, Hankinson SE, Hunter DJ (2007) A polymorphism in the 3\u2032 untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study. Breast Cancer Res 9:R3","journal-title":"Breast Cancer Res"},{"key":"1082_CR11","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/cncr.21763","volume":"106","author":"L Gallicchio","year":"2006","unstructured":"Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang H-Y, Hoffman SC, Helzlsouer KJ (2006) Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer 106:1443\u20131452","journal-title":"Cancer"},{"key":"1082_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/15287390701289966","volume":"70","author":"J Gao","year":"2007","unstructured":"Gao J, Ke Q, Ma H-X, Wang Y, Zhou Y, Hu Z-B, Zhai X-J, Wang X-C, Qing J-W, Chen W-S, Jin G-F, Liu J-Y, Tan Y-F, Wang X-R, Shen H-B (2007) Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population. J Toxicol Environ Health A 70:908\u2013915","journal-title":"J Toxicol Environ Health A"},{"key":"1082_CR13","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1158\/1078-0432.CCR-05-2055","volume":"12","author":"U Langsenlehner","year":"2006","unstructured":"Langsenlehner U, Yazdani-Biuki B, Eder T, Renner W, Wascher TC, Paulweber B, Weitzer W, Samonigg H, Krippl P (2006) The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk. Clin Cancer Res 12:1392\u20131394","journal-title":"Clin Cancer Res"},{"key":"1082_CR14","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1158\/1055-9965.EPI-05-0291","volume":"14","author":"PG Moorman","year":"2005","unstructured":"Moorman PG, Sesay J, Nwosu V, Kane JG, de Cotret AR, Worley K, Millikan R (2005) Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women. Cancer Epidemiol Biomarkers Prev 14:3013\u20133014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1082_CR15","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1186\/bcr1629","volume":"8","author":"J Shen","year":"2006","unstructured":"Shen J, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM (2006) Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk. Breast Cancer Res 8:R71","journal-title":"Breast Cancer Res"},{"key":"1082_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/carcin\/bgl170","volume":"28","author":"U Vogel","year":"2007","unstructured":"Vogel U, Christensen J, Nexo BA, Wallin H, Friis S, Tjonneland A (2007) Peroxisome profilerator-activated receptorgamma2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 28:427\u2013434","journal-title":"Carcinogenesis"},{"key":"1082_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.clon.2008.12.005","volume":"21","author":"F Li","year":"2009","unstructured":"Li F, Ren G-S, Li HY, Wang XY, Chen L, Li J (2009) A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer. Clin Oncol 21:302\u2013305","journal-title":"Clin Oncol"},{"issue":"3","key":"1082_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/carcin\/bgp307","volume":"31","author":"L Dossus","year":"2009","unstructured":"Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le Marchand L, Lund E, Peeters PH, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler RG, Cox DG (2009) PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis 31(3):455\u2013461","journal-title":"Carcinogenesis"},{"key":"1082_CR19","first-page":"671","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"A Burke","year":"2006","unstructured":"Burke A, Smyth E, FitzGerald GA (2006) Analgesic-antipyretic agents: pharmacotherapy of gout. In: Brunton LL, Lazlo JS, Parker KL (eds) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York, pp 671\u2013716","edition":"11"},{"key":"1082_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1158\/1055-9965.53.14.1","volume":"14","author":"MR Bonner","year":"2005","unstructured":"Bonner MR, Han D, Nie J, Rogerson P, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14:53\u201360","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1082_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10552-005-1906-x","volume":"16","author":"MR Bonner","year":"2005","unstructured":"Bonner MR, Nie J, Han D, Vena JE, Rogerson P, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States). Cancer Causes Control 16:683\u2013689","journal-title":"Cancer Causes Control"},{"key":"1082_CR22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1158\/1055-9965.1480.13.9","volume":"13","author":"SE McCann","year":"2004","unstructured":"McCann SE, Ip C, Ip MM, McGuire MK, Muti P, Edge SB, Trevisan M, Freudenheim JL (2004) Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev 13:1480\u20131484","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1082_CR23","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1002\/ijc.22236","volume":"119","author":"D Han","year":"2006","unstructured":"Han D, Nie J, Bonner MR, McCann SE, Muti P, Trevisan M, Ramirez-Marrero FA, Vito D, Freudenheim JL (2006) Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study. Int J Cancer 119:2931\u20132937","journal-title":"Int J Cancer"},{"key":"1082_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0149-2918(00)80043-0","volume":"22","author":"EV Hersh","year":"2000","unstructured":"Hersh EV, Moore PA, Ross GL (2000) Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 22:500\u2013548","journal-title":"Clin Ther"},{"key":"1082_CR25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature06258","volume":"449","author":"KA Frazer","year":"2007","unstructured":"International HapMap Consortium, Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S, Wheeler DA, Willis TD, Yu F, Yang H, Zeng C, Gao Y, Hu H, Hu W, Li C, Lin W, Liu S, Pan H, Tang X, Wang J, Wang W, Yu J, Zhang B, Zhang Q, Zhao H, Zhao H, Zhou J, Gabriel SB, Barry R, Blumenstiel B, Camargo A, Defelice M, Faggart M, Goyette M, Gupta S, Moore J, Nguyen H, Onofrio RC, Parkin M, Roy J, Stahl E, Winchester E, Ziaugra L, Altshuler D, Shen Y, Yao Z, Huang W, Chu X, He Y, Jin L, Liu Y, Shen Y, Sun W, Wang H, Wang Y, Wang Y, Xiong X, Xu L, Waye MMY, Tsui SKW, Xue H, Wong JT-F, Galver LM, Fan J-B, Gunderson K, Murray SS, Oliphant AR, Chee MS, Montpetit A, Chagnon F, Ferretti V, Leboeuf M, Olivier J-F, Phillips MS, Roumy S, Sallee C, Verner A, Hudson TJ, Kwok P-Y, Cai D, Koboldt DC, Miller RD, Pawlikowska L, Taillon-Miller P, Xiao M, Tsui L-C, Mak W, Song YQ, Tam PKH, Nakamura Y, Kawaguchi T, Kitamoto T, Morizono T, Nagashima A et al (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851\u2013861","journal-title":"Nature"},{"key":"1082_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/ng1669","volume":"37","author":"PIW Bakker de","year":"2005","unstructured":"de Bakker PIW, Yelensky R, Pe\u2019er I, Gabriel SB, Daly MJ, Altshuler D (2005) Efficiency and power in genetic association studies. Nat Genet 37:1217\u20131223 (see comment)","journal-title":"Nat Genet"},{"key":"1082_CR27","first-page":"565","volume":"129","author":"X Zhang","year":"2005","unstructured":"Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129:565\u2013576","journal-title":"Gastroenterology"},{"key":"1082_CR28","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1161\/01.ATV.0000030340.80207.C5","volume":"22","author":"A Papafili","year":"2002","unstructured":"Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ (2002) Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22:1631\u20131636 (see comment)","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1082_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/gepi.10252","volume":"25","author":"F Dudbridge","year":"2003","unstructured":"Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115\u2013121","journal-title":"Genet Epidemiol"},{"key":"1082_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11033-009-9685-1","volume":"37","author":"W Zhu","year":"2010","unstructured":"Zhu W, Wei B, Shan X (2010) 765>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case\u2013control studies. Mol Biol Rep 37:277\u2013288","journal-title":"Mol Biol Rep"},{"key":"1082_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.bjc.6603874","volume":"97","author":"I Cheng","year":"2007","unstructured":"Cheng I, Liu X, Plummer SJ, Krumroy LM, Casey G, Witte JS (2007) COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. Br J Cancer 97:557\u2013561","journal-title":"Br J Cancer"},{"key":"1082_CR32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-3565(24)29252-1","volume":"299","author":"E Fritsche","year":"2001","unstructured":"Fritsche E, Baek SJ, King LM, Zeldin DC, Eling TE, Bell DA (2001) Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther 299:468\u2013476","journal-title":"J Pharmacol Exp Ther"},{"key":"1082_CR33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2174\/1381612043453171","volume":"10","author":"DA Dixon","year":"2004","unstructured":"Dixon DA (2004) Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des 10:635\u2013646","journal-title":"Curr Pharm Des"},{"key":"1082_CR34","doi-asserted-by":"publisher","first-page":"23179","DOI":"10.1074\/jbc.M008461200","volume":"276","author":"SJ Cok","year":"2001","unstructured":"Cok SJ, Morrison AR (2001) The 3\u2032-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 276:23179\u201323185","journal-title":"J Biol Chem"},{"key":"1082_CR35","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/jnci\/92.14.1151","volume":"92","author":"S Wacholder","year":"2000","unstructured":"Wacholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92:1151\u20131158 (see comment)","journal-title":"J Natl Cancer Inst"},{"key":"1082_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/oem.52.8.557","volume":"52","author":"S Wacholder","year":"1995","unstructured":"Wacholder S, Hartge P, Lubin JH, Dosemeci M (1995) Non-differential misclassification and bias towards the null: a clarification. Occup Environ Med 52:557\u2013558 (see comment)","journal-title":"Occup Environ Med"},{"key":"1082_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/aje\/kwg147","volume":"158","author":"LM Morimoto","year":"2003","unstructured":"Morimoto LM, White E, Newcomb PA (2003) Selection bias in the assessment of gene\u2013environment interaction in case\u2013control studies. Am J Epidemiol 158:259\u2013263","journal-title":"Am J Epidemiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1082-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1082-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T15:47:42Z","timestamp":1740325662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1082-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1082-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,30]]}}}